SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Statistical Methods in Medical Research
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0962280207087309v1
17/6/643    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mahnken, J. D
Right arrow Articles by Freeman, J. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahnken, J. D
Right arrow Articles by Freeman, J. L
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach

Jonathan D Mahnken

Department of Biostatistics, Center for Biostatistics and Advanced Informatics, University of Kansas Medical Center, MSN 1026, 3901 Rainbow Blvd., Kansas City, KS 66160, USA, jmahnken{at}kumc.edu

Wenyaw Chan

Division of Biostatistics, School of Public Health, University of Texas - Health Science Center, 1200 Herman Pressler, Houston, TX 77030, USA

Daniel H Freeman, Jr

Office of Biostatistics, Department of Preventive Medicine and Community Health, University of Texas Medical Branch, 700 Harborside Drive, Galveston, TX 77555-1148, USA

Jean L Freeman

Sealy Center on Aging, Department of Internal Medicine, Department of Preventive Medicine and Community Health, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-0460, USA

Measuring the benefit of screening mammography is difficult due to lead-time bias, length bias and over-detection. We evaluated the benefit of screening mammography in reducing breast cancer mortality using observational data from the SEER-Medicare linked database. The conceptual model divided the disease duration into two phases: preclinical (T0) and symptomatic (T1) breast cancer. Censored information for the bivariate response vector ( T0, T1) was observed and used to generate a likelihood function. However, the contribution to the likelihood function for some observations could not be calculated analytically, thus, censoring boundaries for these observations were modified. Inferences about the impact of screening mammography on breast cancer mortality were made based on maximum likelihood estimates derived from this likelihood function. Hazard ratios (95% confidence intervals) of 0.54 (0.48—0.61) and 0.33 (0.26— 0.42) for single and regular users (vs. non-users), respectively, demonstrated a protective effect of screening mammography among women 69 years and older. This method reduced the impact of lead-time bias, length bias and over-detection, which biased the estimated hazard ratios derived from standard survival models in favour of screening.

This version was published on December 1, 2008

Statistical Methods in Medical Research, Vol. 17, No. 6, 643-663 (2008)
DOI: 10.1177/0962280207087309


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement